Astek Diagnostics Raises Funding to Expand Operations and Reach

Astek Diagnostics' Pre-Series A Investment

Key Highlights:

• Pre-Series A Investment: Astek Diagnostics, a developer of urine-based diagnostic tools, received a Pre-Series A investment from She's Independent.
• Investor Network: Other investors include Y Combinator, AYANA Capital, Wexford Scitech Venture Fund, Harvard Management Seed Capital, TEDCO, Maryland Momentum Fund, Goldin Ventures, Maryland Technology Development Corporation, Maryland Innovation Initiative, Maryland Industrial Partnerships, Key Technologies, Abell Foundation, and prominent angel investors.
• Expansion Plans: The funding will be used to expand operations and business reach.

Astek Diagnostics' Target Market

• Target Market: Medical clinics, hospitals, and healthcare providers in need of urine-based diagnostic tools.
• Urology Clinics: Collaborations with urology clinics to demonstrate the feasibility of the Jiddu Analyzer in clinical studies.
• Medical Research Institutions: Partnerships with research institutions and organizations focused on advancing diagnostic technologies.

What Astek Diagnostics Needs to Buy

• Manufacturing and Supply Chain Solutions: Collaborating with manufacturers for the production of the Jiddu Analyzer and managing a reliable supply chain.
• Regulatory Compliance Services: Engaging with regulatory experts to navigate the FDA marketing authorization application process and ensure compliance.
• Marketing and Sales Support: Services to support market expansion, customer acquisition, and effective marketing and sales strategies.